Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Apelin Levels in HFrEF and Association with Sustained VT Detected by ICD Interrogation: A Retrospective Pilot Study. | J Cardiovasc Dev Dis | 2026 | 41745327 | PubTator, text mining | PubMed |
| From hPSCs to MSCs: differentiation strategies, pathways, and the emergence of common regulatory networks. | Cell Mol Biol Lett | 2026 | 41735837 | PubTator, text mining | PubMed |
| Cross-Platform Transcriptomic Analysis of 40 Human and Rodent Skeletal Muscle Exerkines. | Muscles | 2026 | 41718082 | PubTator, text mining | PubMed |
| Pathological mechanisms and clinical research progress of endothelial dysfunction. | Front Cardiovasc Med | 2026 | 41717580 | PubTator, text mining | PubMed |
| A narrative review on the correlation between diabetic foot and sarcopenia. | Front Endocrinol (Lausanne) | 2026 | 41717550 | PubTator, text mining | PubMed |
| Apelin-36 attenuates diabetic glomerular endothelial hyperpermeability via the KLF2/Occludin pathway. | Peptides | 2026 | 41690598 | PubTator, text mining | PubMed |
| Allelic Variation at 9p21.3 Orchestrates Widespread RNA Splicing Shifts Governing Vascular Smooth Muscle Cell Plasticity. | bioRxiv | 2026 | 41648216 | PubTator, text mining | PubMed |
| γ-Radiation Induces Long-Term Dose-Related Proteomic and Phosphorylated-Tau Species Changes in Non-Human Primate Hippocampus. | Res Sq | 2026 | 41646401 | PubTator, text mining | PubMed |
| SIRT3-dependent enhancement of apelinergic signaling mediates the cardioprotective effects of late-life high-intensity interval training. | J Physiol Sci | 2026 | 41619329 | PubTator, text mining | PubMed |
| Altitude hypoxia and hypoxemia: pathogenesis and management. | Signal Transduct Target Ther | 2026 | 41571626 | PubTator, text mining | PubMed |
| Research trends and frontiers of the Apelin system in kidney diseases: a multi-database bibliometric analysis and cross-validation study. | Int Urol Nephrol | 2026 | 41563689 | PubTator, text mining | PubMed |
| <p>Prolyl hydroxylase domain proteins: Localization, regulation, function and their role in erythropoiesis (Review)</p>. | Mol Med Rep | 2026 | 41543162 | PubTator, text mining | PubMed |
| Exercise-induced changes in circulatory aging-related biomarkers among older adults: longitudinal analysis of a multi-stage randomized clinical trial. | Immun Ageing | 2026 | 41535906 | PubTator, text mining | PubMed |
| Correlation of G protein-coupled receptor and tumor microenvironment with gastric cancer outcomes and therapies. | Chin Med J (Engl) | 2026 | 41486495 | PubTator, text mining | PubMed |
| Screening apelin analogues and a small molecule agonist as effective cardiovascular therapeutics against reperfusion injury. | RSC Med Chem | 2026 | 41424684 | PubTator, text mining | PubMed |
| Apelin signaling acts as a molecular switch between endothelial and hematopoietic stem cell fates. | EMBO Rep | 2026 | 41402492 | PubTator, text mining | PubMed |
| Apelin-13 alleviated ischemia reperfusion injury via KLF2/NF-κB signaling pathway after kidney transplantation. | Int Immunopharmacol | 2026 | 41223609 | PubTator, text mining | PubMed |
| Cardioprotective Effects of Apelin in Myocardial Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis. | J Cardiovasc Pharmacol | 2026 | 41150851 | PubTator, text mining | PubMed |
| Apelin-12 Attenuates LPS-Induced Cellular Senescence in Human Dental Pulp Cells via SIRT6-Mediated Pathways: Implications for Gingivitis Management. | Mol Oral Microbiol | 2026 | 41109967 | PubTator, text mining | PubMed |
| Apelin: A Promising Therapeutic Target for Degenerative Diseases of the Musculoskeletal System. | Aging Dis | 2025 | 42552064 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=3